中国寄生虫学与寄生虫病杂志 ›› 1990, Vol. 8 ›› Issue (2): 100-103.

• • 上一篇    下一篇

丙氧达唑治疗钩虫、蛔虫和鞭虫感染的效果

黄一心,周家修,薛忠权,吴芸轩,陈锦英,吴荷珍,季美华,沈怡平,曹国群,吴中兴,陈有贵,郑葵阳,祝惠民,戴梅秀,保和珍,沈志芳,胡文英,方政,彭光仁,徐曼玲,王瑞云,屠聿脩   

  1. 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 江苏省寄生虫病防治研究所; 徐州医学院; 徐州医学院; 徐州医学院; 徐州医学院; 徐州医学院; 南通医学院; 南通医学院; 南通医学院; 南通医学院; 南通医学院; 南通医学院; 南京医学院第一附属医院; 南京医学院第一附属医院
  • 收稿日期:2017-01-09 修回日期:2017-01-09 出版日期:1990-05-31 发布日期:2017-01-09

CLINICAL OBSERVATIONS ON THE TREATMENT OF HOOKWORM, ASCARIS AND TRICHURIS INFECTION WITH OXIBENDAZOLE

  • Received:2017-01-09 Revised:2017-01-09 Online:1990-05-31 Published:2017-01-09

摘要: 采用双盲法观察丙氧达唑每天15mg/kg×3d治疗钩虫、蛔虫和鞭虫感染者340、196和178例的效果。其钩虫、蛔虫和鞭虫卵阴转率分别为70.3~80.6、92.5~97.8和67.0~71.0%。十二指肠钩虫和美洲钩虫幼虫的阴转率分别为77.7和83.2%。钩虫卵减少率为98.1~98.6%。口服噻嘧啶每天10mg/kg(基质)×3d后,上述三种虫卵的阴转率依次为73.5、90.0和28.8%,钩虫卵减少率为98.8%。口服安慰剂后,上述三种虫卵的阴转率依次为6.5、29.7和7.9%。服药后均未发现严重不良反应。

关键词: 丙氧达唑, 驱蠕虫药, 钩虫, 蛔虫, 鞭虫, 临床观察

Abstract: 340 cases of hookworm infection, 196 cases of ascariasis and 178 cases of trichuriasis were treated with an anthelmintic, oxibendazole, 15mg/kg·d × 3d; 102, 70 and 66 cases of respective infections were treated with pyrantel 10mg/kg·d×3d and 108, 74 and 63 cases took placebo for comparison and as control under double-blind observations. Re-examinations of the stool were performed after the treatment. Among the cases treated with oxibendazole, the egg negative conversion rates of hookworm, Ascaris and Trichuris were 70.3-80.6%, 92.5-97.8 and 67.0-71.0% respectively. The egg reduction rates of hookworm were 98.1-98.6%. The larval negative conversion rates of Ancylostoma duodenale and Necator americanus were 77.7 and 83.2% respectively. Among the cases treated with pyrantel, the egg negative conversion rates of the three above mentioned parasites were 73.5, 90.0 and 28.8% respectively. The egg reduction rate of hookworm was 98.8%. Among the cases treated with placebo, the egg negative conversion rates of the three above mentioned parasites were 6.5, 29.7 and 7.9%. No marked adverse reactions were observed by clinical and laboratory examinations.